Multiple apolipoprotein IVD, control - UK MHRA Medical Device Registration

Multiple apolipoprotein IVD, control is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 134483. The device is manufactured by LGC Clinical Diagnostics, Inc. from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Wellkang Ltd.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

MHRA Registered

In Vitro Diagnostic Device

🇬🇧

Multiple apolipoprotein IVD, control

MHRA Device ID: 134483•Ref: 134483

Device Type

In Vitro Diagnostic Device

Devices

Multiple apolipoprotein IVD, control

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Oct 17, 2023

Manufacturer Information

Name

LGC Clinical Diagnostics, Inc.

Address

221 US Route 1

Cumberland Foreside, ME, United States

Created Date

Jan 17, 2022

Authorized Representative

Name

Wellkang Ltd

Relationship Type

Authorised Representative (Northern Ireland)

Address

Enterprise Hub, NW Business Complex 1 Beraghmore Road

Derry, Northern Ireland, Northern Ireland, United Kingdom

Postcode: BT48 8SE

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Other Products from LGC Clinical Diagnostics, Inc. (10)

Other Products from Same Authorized Representative (10)

Multiple apolipoprotein IVD, control - UK MHRA Medical Device Registration

Device Type

Devices

Type

Date Registered

Last Updated

Name

Address

Created Date

Name

Relationship Type

Address

DJ Fang

Alpha-fetoprotein (AFP) IVD, kit, fluorescent immunoassay

Cyclic citrullinated peptide antibody (anti-CCP) IVD, kit, fluorescent immunoassay

Streptococcus pneumoniae antigen IVD, kit, rapid ICT, clinical

Allergen-specific/total immunoglobulin E (IgE) antibody IVD, kit, fluorescent immunoassay

C-reactive protein (CRP) IVD, kit, fluorescent immunoassay

Cryptosporidium species antigen IVD, kit, rapid ICT, clinical

Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical

SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing

Trichomonas vaginalis antigen IVD, kit, rapid ICT, clinical

D-dimer IVD, kit, fluorescent immunoassay

Multiple-type clinical chemistry analyte profile IVD, control

Adrenocorticotropic hormone (ACTH) IVD, control

Cancer antigen 15-3 (CA15-3) IVD, control

Cancer antigen 19-9 (CA19-9) IVD, control

Ferritin IVD, control

Heparin anti-Xa IVD, control

Multiple cardiac marker IVD, control

Multiple form 25-hydroxy Vitamin D IVD, control

Multiple thyroid marker IVD, control

Troponin T IVD, control

Isocitrate dehydrogenase 1/isocitrate dehydrogenase 2 (IDH1/IDH2) gene mutation IVD, kit, nucleic acid technique (NAT)

Human papillomavirus (HPV) high risk strain nucleic acid IVD, kit, nucleic acid technique (NAT)

Influenza A virus H1N1 subtype (swine influenza) nucleic acid IVD, kit, nucleic acid technique (NAT)

Adenovirus nucleic acid IVD, kit, nucleic acid technique (NAT)

Colorectal cancer genotyping IVD, kit, nucleic acid technique (NAT)

Dengue virus nucleic acid IVD, kit, nucleic acid technique (NAT)

Epstein-Barr virus (EBV) nucleic acid IVD, kit, nucleic acid technique (NAT)

B-cell acute lymphoblastic leukaemia (B-ALL) genetic mutation IVD, kit, nucleic acid technique (NAT)

Adenovirus nucleic acid IVD, kit, nucleic acid technique (NAT)

Multidrug-resistant nontuberculous Mycobacterium (NTM) nucleic acid IVD, kit, nucleic acid technique (NAT)